Trial Profile
Phase I Trial Evaluating Continuous Infusion of Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 May 2022
Price :
$35
*
At a glance
- Drugs Cilengitide (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 10 May 2010 New trial record